We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biotech Growth Trust (the) Plc | LSE:BIOG | London | Ordinary Share | GB0000385517 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-11.00 | -1.17% | 931.00 | 926.00 | 931.00 | 940.00 | 930.00 | 940.00 | 125,516 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | -32.42M | -41.3M | -1.0034 | -9.29 | 383.6M |
TIDMBIOG For immediate release 21 October 2016 THE BIOTECH GROWTH TRUST PLC (the "Company") MARKET PURCHASE OF COMPANY'S OWN SHARES Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held 12 July 2016 to make market purchases of the Company's own shares up to an aggregate maximum of 8,754,920 that a market total of 86,989 Ordinary shares of 25p each in the capital of the Company were purchased on Friday, 21 October 2016 for cancellation by the Company at a price of 691.06 pence per share. Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 56,397,708. The Company does not currently hold any Ordinary shares in treasury. The figure of 56,397,708 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules. For and on behalf of Frostrow Capital LLP Company Secretary For further information, please contact: Mark Pope Frostrow Capital LLP Tel: 020 3 170 4913 END
(END) Dow Jones Newswires
October 21, 2016 12:35 ET (16:35 GMT)
1 Year Biotech Growth Chart |
1 Month Biotech Growth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions